BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2956101)

  • 1. Arterial blood infusion for myocardial protection during percutaneous transluminal coronary angioplasty.
    Timmis AD; Griffin B; Crick JC; Sowton E
    Eur Heart J; 1987 Apr; 8(4):340-6. PubMed ID: 2956101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The evolution of myocardial ischaemia during percutaneous transluminal coronary angioplasty.
    Griffin B; Timmis AD; Crick JC; Sowton E
    Eur Heart J; 1987 Apr; 8(4):347-53. PubMed ID: 2956102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional myocardial dysfunction during coronary angioplasty: evaluation by two-dimensional echocardiography and 12 lead electrocardiography.
    Wohlgelernter D; Cleman M; Highman HA; Fetterman RC; Duncan JS; Zaret BL; Jaffe CC
    J Am Coll Cardiol; 1986 Jun; 7(6):1245-54. PubMed ID: 2940283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the time interval between the first and second balloon inflations on ischemic preconditioning during percutaneous transluminal coronary angioplasty].
    Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
    J Cardiol; 1996 Jun; 27(6):303-8. PubMed ID: 9062590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical applications of coronary sinus retroperfusion during high risk percutaneous transluminal coronary angioplasty.
    Incorvati RL; Tauberg SG; Pecora MJ; Macherey RS; Krucoff MW; Dianzumba SB; Donohue BC
    J Am Coll Cardiol; 1993 Jul; 22(1):127-34. PubMed ID: 8509532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of left ventricular performance during percutaneous transluminal coronary angioplasty: a study by intravenous digital subtraction ventriculography.
    Norell MS; Lyons JP; Gershlick AH; Gardener JE; Rothman MT; Layton CA; Balcon R
    Br Heart J; 1988 Apr; 59(4):419-28. PubMed ID: 2967085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silent ischemia during coronary occlusion produced by balloon inflation: relation to regional myocardial dysfunction.
    Wohlgelernter D; Jaffe CC; Cabin HS; Yeatman LA; Cleman M
    J Am Coll Cardiol; 1987 Sep; 10(3):491-8. PubMed ID: 2957410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in myocardial echo amplitude during reversible ischaemia in humans.
    Lythall DA; Gibson DG; Kushwaha SS; Norell MS; Mitchell AG; Ilsley CJ
    Br Heart J; 1992 May; 67(5):368-76. PubMed ID: 1389716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mechanical and electrocardiographic sequence of coronary artery occlusion: an echocardiographic study during coronary angioplasty].
    Akasaka T; Yoshikawa J; Yoshida K; Kato H; Okumachi F; Koizumi K; Shiratori K; Takao S; Asaka T; Shakudo M
    J Cardiogr; 1986 Dec; 16(4):819-30. PubMed ID: 2963073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration by nitroglycerin of left ventricular ischemia induced by percutaneous transluminal coronary angioplasty: assessment by hemodynamic variables and left ventriculography.
    Doorey AJ; Mehmel HC; Schwarz FX; Kübler W
    J Am Coll Cardiol; 1985 Aug; 6(2):267-74. PubMed ID: 3160755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary venous lipid peroxide concentrations after coronary angioplasty: correlation with biochemical and electrocardiographic evidence of myocardial ischaemia.
    Oldroyd KG; Paterson JR; Rumley AG; Eteiba H; Rae AP; Shepherd J; Cobbe SM; Hutton I
    Br Heart J; 1992 Jul; 68(1):43-7. PubMed ID: 1515290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preconditioning of human myocardium with adenosine during coronary angioplasty.
    Leesar MA; Stoddard M; Ahmed M; Broadbent J; Bolli R
    Circulation; 1997 Jun; 95(11):2500-7. PubMed ID: 9184580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of ischemia during percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20%.
    Cleman M; Jaffee CC; Wohlgelernter D
    Circulation; 1986 Sep; 74(3):555-62. PubMed ID: 2943533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of ST segment elevation and regional wall motion with open-artery, intracoronary Fluosol.
    Schaer GL; Krucoff MW; Green C; Visner MS
    Am Heart J; 1989 Oct; 118(4):679-85. PubMed ID: 2529747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complex coronary angioplasty: a technique for dilatation of bifurcation stenoses.
    Pinkerton CA; Slack JD
    Angiology; 1985 Aug; 36(8):543-8. PubMed ID: 2931038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of time interval between two balloon inflations on ischemic preconditioning during coronary angioplasty.
    Tanaka T; Oka Y; Tawara I; Sada T; Kira Y
    Cathet Cardiovasc Diagn; 1997 Nov; 42(3):263-7. PubMed ID: 9367098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synchronized coronary venous retroperfusion: protection from ischemia in coronary angioplasty (PTCA)].
    Nienaber CA; Rehders TC; Abend M; Chen C
    Z Kardiol; 1992 Dec; 81(12):645-55. PubMed ID: 1492432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the ischemic myocardium during percutaneous transluminal coronary angioplasty.
    Zalewski A; Savage M; Goldberg S
    Am J Cardiol; 1988 May; 61(14):54G-60G. PubMed ID: 2896457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of left ventricular ejection fraction during percutaneous transluminal coronary angioplasty by distal transcatheter coronary perfusion of oxygenated Fluosol DA 20%.
    Jaffe CC; Wohlgelernter D; Cabin H; Bowman L; Deckelbaum L; Remetz M; Cleman M
    Am Heart J; 1988 Jun; 115(6):1156-64. PubMed ID: 2967624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mechanism of ischemic preconditioning during percutaneous transluminal coronary angioplasty.
    Inoue T; Fujito T; Hoshi K; Sakai Y; Yamaguchi H; Takayanagi K; Morooka S; Takabatake Y
    Cardiology; 1996; 87(3):216-23. PubMed ID: 8725317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.